Primary Site >> Pancreatic Cancer
Gene >> TENM1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Pancreatic cancer. Epidemiology, etiology, diagnosis and therapy]. PMID: 6857193 |
Ref: [Perioperative staging and the Munster TNM classification in ampullary and pancreatic cancer]. PMID: 2414617 |
Ref: Evaluation of intraoperative radiotherapy for carcinoma of the pancreas: prognostic factors and survival analyses. PMID: 3140298 Ref: [The TNM classification of pancreas cancer]. PMID: 3377650 |
Ref: [Effect of tumor size and lymph node status on the prognosis of pancreatic cancer]. PMID: 2541980 |
Ref: Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. PMID: 2183284 |
Ref: Staging of exocrine pancreatic carcinoma. PMID: 2015921 |
Ref: [Free intraperitoneal tumors cells in pancreatic cancer--significance for clinical course and therapy]. PMID: 1380421 |
Ref: Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. PMID: 7682052 Ref: Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study. PMID: 7684003 Ref: Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. PMID: 8383381 Ref: Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study. PMID: 8384066 |
Ref: Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987-1991. PMID: 7940184 |
Ref: Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Kloppel vs TNM grading. PMID: 7642975 Ref: The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals. PMID: 7717777 Ref: Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. PMID: 7804972 Ref: Pancreatic cancer treatment in the U.S. veteran from 1987 to 1991: effect of tumor stage on survival. PMID: 7844979 Ref: Carcinoma of the pancreatic head area. Diagnostic imaging: computed tomography. PMID: 8559968 |
Ref: Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer. PMID: 8604235 Ref: Surgical treatment of pancreatic adenocarcinoma: Taiwan experience. PMID: 8803707 Ref: Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. PMID: 8979062 |
Ref: Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients. PMID: 9209952 |
Ref: [Studies on TNM classification of carcinoma of the exocrine pancreas]. PMID: 9464343 Ref: Assessment of risk factors for pancreatic resection for cancer. PMID: 9494415 Ref: [Epidemiological and clinical aspects of pancreatic cancer in Senegal]. PMID: 10797965 |
Ref: Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma. PMID: 10449813 Ref: Tumors of the gastrointestinal tract and the pancreas: histopathology, staging and prognosis. PMID: 10470164 |
Ref: [Echolaparoscopy in the staging of abdominal neoplasms. Prospective study]. PMID: 10920491 Ref: EUS in preoperative staging of pancreatic cancer. PMID: 11023561 |
Ref: Pancreatic adenocarcinoma: detection and staging with dynamic MR imaging. PMID: 11335097 Ref: Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. PMID: 11408922 Ref: Prognostic significance of c-erbB-2 gene expression in pancreatic cancer patients. PMID: 11583287 |
Ref: Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. PMID: 12429967 |
Ref: [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas]. PMID: 12948419 Ref: Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma. PMID: 14636255 |
Ref: Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. PMID: 15056091 Ref: [Clinical analysis of 2340 cases of pancreatic cancer]. PMID: 15059537 Ref: Confusion by frequent changes in staging of exocrine pancreatic carcinoma. PMID: 15367882 |
Ref: Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. PMID: 15372209 Ref: [Endoscopic ultrasonography in pancreatic carcinoma]. PMID: 16119317 Ref: Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. PMID: 16234519 Ref: [Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer]. PMID: 16274040 Ref: [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance]. PMID: 16274047 Ref: Interventional gastroenterology: esophageal and pancreatic cancers. PMID: 16360009 |
Ref: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. PMID: 16847382 |
Ref: Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. PMID: 17171495 Ref: Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. PMID: 17552012 Ref: Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. PMID: 17589944 |
Ref: Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. PMID: 18367131 Ref: Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. PMID: 18853313 Ref: Clinical and pathologic prognostic factors for curative resection for pancreatic cancer. PMID: 18982152 Ref: Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma. PMID: 19080330 Ref: [Prospective evaluation of ultrasonography, multi-slice spiral CT, endoscopic ultrasonography, and magnetic resonance imaging in assessment of TNM staging and assessment of resectability in pancreatic carcinoma]. PMID: 19080491 Ref: [The clinical significance of heparanase expression in human pancreatic carcinoma tissue]. PMID: 19094632 |
Ref: Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. PMID: 18715612 Ref: [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage]. PMID: 19211081 Ref: Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China. PMID: 19236544 Ref: [Role of prostate stem cell antigen in human pancreatic carcinoma: a tissue microarray-based study]. PMID: 19861285 Ref: Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case. PMID: 21318999 |
Ref: Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. PMID: 19819644 Ref: Value of endoscopic ultrasonography-guided fine needle aspiration (FNA) in the diagnosis of neoplastic tumor(-like) pancreatic lesions in daily clinical practice. PMID: 19899026 Ref: Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters. PMID: 19908168 Ref: [Diagnosis and assessment of pancreatic cancer]. PMID: 20444407 |
Ref: TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience. PMID: 21360536 Ref: The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature. PMID: 21843922 Ref: Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. PMID: 21926543 Ref: Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1. PMID: 22173495 Ref: Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumors. PMID: 27895674 |
Ref: The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. PMID: 22082308 Ref: Correlation between spiral CT preoperative staging of pancreatic cancer and PTEN and COX-2 expression. PMID: 22389271 Ref: Expression of A20 is reduced in pancreatic cancer tissues. PMID: 22461193 Ref: TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. PMID: 22525418 Ref: Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas. PMID: 22811937 Ref: [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer]. PMID: 23157907 |
Ref: Pancreatic cancer in Saudi patients treated at tertiary institution. Ten years retrospective study. PMID: 23756925 Ref: MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PMID: 24040078 Ref: Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. PMID: 24053229 |
Ref: Potential effects of Mina53 on tumor growth in human pancreatic cancer. PMID: 24522517 Ref: Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PMID: 24667580 Ref: Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors. PMID: 24945681 Ref: Evaluation of TNM status changes between the first two CT scans in patients with pancreatic cancer. PMID: 25373589 |
Ref: Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions. PMID: 25183049 Ref: Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma. PMID: 25890028 Ref: Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. PMID: 25928025 Ref: [A new classification of pancreatic cancer to guide operative decisions and the comparison with the TNM stage]. PMID: 26359069 Ref: The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer. PMID: 26652622 Ref: Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis. PMID: 26662432 Ref: Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer. PMID: 26782462 |
Ref: Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer. PMID: 26590104 Ref: CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine. PMID: 26894380 Ref: CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. PMID: 27073726 Ref: MiR-548an, Transcriptionally Downregulated by HIF1alpha/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. PMID: 27353169 Ref: Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma. PMID: 27399091 Ref: Increased expression of alphaTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection. PMID: 27447976 Ref: [ARID1A expression of SWI/SNF remodeling complex in pancreatic neuroendocrine tumor]. PMID: 27510785 Ref: Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer. PMID: 27550487 Ref: Pancreatic carcinoma masked as fever of unknown origin: A case report and comprehensive review of literature. PMID: 27583884 Ref: The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients. PMID: 27665172 Ref: Long noncoding RNA uc.345 promotes tumorigenesis of pancreatic cancer by upregulation of hnRNPL expression. PMID: 27689400 Ref: Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. PMID: 27732623 Ref: Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer. PMID: 27788483 |
Ref: Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. PMID: 27322188 Ref: LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. PMID: 28415631 Ref: Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis. PMID: 28416756 Ref: Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1. PMID: 28506766 Ref: Expression of PRR11 protein and its correlation with pancreatic cancer and effect on survival. PMID: 28599413 Ref: Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size. PMID: 28620676 Ref: Latent Transforming Growth Factor beta Binding Protein 2 (LTBP2) as a Novel Biomarker for the Diagnosis and Prognosis of Pancreatic Carcinoma. PMID: 28669978 Ref: Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. PMID: 28759959 Ref: Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades. PMID: 28786064 Ref: Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. PMID: 29169392 Ref: miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. PMID: 29196101 Ref: MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. PMID: 29224010 Ref: On the significance of Tim-3 expression in pancreatic cancer. PMID: 29551917 |
Ref: Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor. PMID: 29107104 Ref: LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients. PMID: 29168159 Ref: Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer. PMID: 29286182 Ref: Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. PMID: 29328401 Ref: MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP. PMID: 29331027 Ref: Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients. PMID: 29398920 Ref: Nomogram for predicting survival in patients with pancreatic cancer. PMID: 29416354 Ref: Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology. PMID: 29472376 Ref: Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. PMID: 29476229 Ref: Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis. PMID: 29483963 Ref: Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities. PMID: 29525378 Ref: Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis. PMID: 29544747 Ref: The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis. PMID: 29561406 Ref: CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer. PMID: 29683068 Ref: Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. PMID: 29709702 Ref: Sulfatase 1 expression in pancreatic cancer and its correlation with clinicopathological features and postoperative prognosis. PMID: 29843217 Ref: Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer. PMID: 29860264 Ref: Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kgamma to Promote Pancreatic Cancer Metastasis. PMID: 29880482 Ref: Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study. PMID: 29914752 Ref: Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. PMID: 29970904 Ref: Tumor size classification of the 8(th) edition of TNM staging system is superior to that of the 7(th) edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy. PMID: 29991730 Ref: Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma. PMID: 30029936 Ref: Tumor grade as significant prognostic factor in pancreatic cancer: validation of a novel TNMG staging system. PMID: 30064236 Ref: Pancreatic cancer survival analysis defines a signature that predicts outcome. PMID: 30092011 Ref: Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma. PMID: 30111807 Ref: [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer]. PMID: 30157579 Ref: [Prognostic Value of Neutrophil-to-lymphocyte Ratio in Patients with Lung Adenocarcinoma Treated with Radical Dissection]. PMID: 30172265 Ref: Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer. PMID: 30178840 Ref: Endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. PMID: 30197399 Ref: Chemotherapy in combination with stereotactic body radiation therapy (SBRT) for oligometastatic pancreatic cancer. PMID: 30219780 Ref: The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible? PMID: 30254003 Ref: The New American Joint Committee on Cancer TNM Staging System for Pancreatic Cancer-Balancing Usefulness With Prognostication. PMID: 30285059 Ref: C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway. PMID: 30311108 Ref: Hydroxyeicosatetraenoic acids in patients with pancreatic cancer: a preliminary report. PMID: 30323978 Ref: Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma. PMID: 30373552 |